Nancy Chang Overview

  • Investor Type
  • Angel
  • Investments
  • 2
  • Portfolio
  • 2

Nancy Chang General Information

Description

Dr. Nancy Chang serves as Chief Executive Officer & Chairperson of the Board at Ansun Biopharma. Nancy was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors from 2007 to 2012. From 1987 to 2007, Dr. Chang served as Co-Founder, President and Chairman of Tanox, Inc., which was sold to Genentech in 2007. Prior to founding Tanox, Dr. Chang held several leadership positions at Centocor, now a division of Johnson & Johnson. She was also an Associate Professor at Baylor College of Medicine. She has served on the board of a number of companies, including SciClone Pharmaceuticals, Inc., Charles River Laboratories International, Inc., Applied Optoelectronics Inc. Nancy received her Doctorate in Biological Chemistry from Harvard University.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 3030 Callan Road
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Nancy Chang Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Rgenix 31-Jul-2015 Early Stage VC 000 Drug Discovery Clinical Trials - Phase 2 00000 00000 00.0
0000000 19-Jun-2015 00000 00000 00.00 Monitoring Equipment Generating Revenue 00000 00000 00.0
To view Nancy Chang’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nancy Chang Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nancy Chang Team (1)

Name Title Deals Funds Boards Office
Nancy Chang Ph.D Angel Investor 0 0 0 San Diego, CA
To view Nancy Chang’s complete team members history, request access »